Frequency and outcome of pulmonary polymethylmethacrylate embolism during percutaneous vertebroplasty

A Venmans1, P N M Lohle, W J van Rooij

  • 1Department of Radiology, St. Elisabeth Ziekenhuis, Tilburg, the Netherlands.

Abstract

Insights

Pulmonary embolism from polymethylmethacrylate (PMMA) cement during percutaneous vertebroplasty (PV) is rare and asymptomatic. Follow-up CT scans show no lasting pulmonary changes, indicating a low risk for patients undergoing PV.

Area of Science:

  • Interventional Radiology
  • Pulmonary Medicine
  • Biomaterials Science

Background:

  • Percutaneous vertebroplasty (PV) uses polymethylmethacrylate (PMMA) cement to treat osteoporotic compression fractures.
  • PMMA cement can migrate into the venous system, potentially causing pulmonary embolism.
  • The frequency, outcomes, and imaging characteristics of PMMA pulmonary embolism are not well understood.

Purpose of the Study:

  • To assess the frequency and clinical outcomes of PMMA pulmonary embolism following PV.
  • To evaluate the relationship between injected PMMA volume and the occurrence of pulmonary embolism.
  • To characterize imaging findings of pulmonary PMMA embolism on CT scans.

Main Methods:

  • Retrospective analysis of 532 PV procedures in 299 patients (2001-2007).
  • Definition of PMMA embolism: venous migration of PMMA toward the lungs, visualized on fluoroscopy.
  • Immediate and 1-year follow-up CT scans were performed for patients with PMMA migration.

Main Results:

  • PMMA embolism occurred in 2.1% of PV procedures (11 patients).
  • CT revealed small peripheral pulmonary PMMA emboli in 8 patients; all remained asymptomatic.
  • No significant difference in injected cement volume was found between patients with and without embolism. 1-year CT showed no reactive changes.

Conclusions:

  • Pulmonary PMMA embolism is an infrequent complication of PV.
  • The complication appears to have no permanent clinical sequelae.
  • No association was found between injected cement volume and PMMA emboli, and no pulmonary reactions were observed on CT after 1 year.

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations: